Hinge Health, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$171M
↑+45.6% +$53Mvs FY2024 (Q4)
Gross Profit
$144M
↑+49.9% +$48Mvs FY2024 (Q4)
Operating Income
$110M
↑+52.1% +$38Mvs FY2024 (Q4)
Net Income
$110M
↑+51.9% +$38Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $171M | $117M |
| COGS | $27M | $21M |
| Gross Profit | $144M | $96M |
| R&D | $33M | $22M |
| SG&A | $0 | $0 |
| D&A | $1M | $1M |
| Other OpEx | $0 | $0 |
| Operating Income | $110M | $72M |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $110M | $72M |
| Tax | $122K | $0 |
| Net Income | $110M | $72M |
QuarterCharts · SEC EDGAR data · HNGE · Comparing FY2025 (Q4) vs FY2024 (Q4)